Literature DB >> 9609227

Factor V Leiden (G1691A), the prothrombin 3'-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci--determination of frequencies in the S. Wales population of the UK.

D J Bowen1, S Bowley, M John, P W Collins.   

Abstract

Simultaneous genetic diagnosis of factor V (FV) Leiden (G1691A), the prothrombin variant (G20210A) and the thermolabile methylenetetrahydrofolate reductase (MTHFR) variant (C677T) has been achieved using multiplex heteroduplex analysis. All three loci are amplified in a single polymerase chain reaction (PCR) containing test DNA and three heteroduplex generators, respectively detecting the three nucleotide substitutions. After PCR, the products are analysed directly without further manipulation and the resulting heteroduplex profiles permit straightforward interpretation of the respective genotypes. The multiplex test has been used to assess the prevalence and allele frequency of each of the three nucleotide substitutions in 300 individuals (150 males and 150 females) from the local (S. Wales) population. A prevalence of 8% and an allele frequency of 0.040 +/- 0.015 (95% confidence interval) was obtained for FV Leiden; the prothrombin variant showed a prevalence of 1% and an allele frequency of 0.007 +/- 0.006 (95% confidence interval); the MTHFR mutation showed a prevalence of 60% and an allele frequency of 0.377 +/- 0.039 (95% confidence interval). This method is applicable to investigation of large cohorts of patients with arterial or venous thrombotic disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609227

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Evaluation of temperature gradient capillary electrophoresis for detection of the Factor V Leiden mutation: coincident identification of a novel polymorphism in Factor V.

Authors:  Kathleen Murphy; Michael Hafez; Juliet Philips; Kellie Yarnell; Kevin Gutshall; Karin Berg
Journal:  Mol Diagn       Date:  2003

2.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults.

Authors:  C F Skibola; M T Smith; E Kane; E Roman; S Rollinson; R A Cartwright; G Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Thermolabile methylenetetrahydrofolate reductase (C677T): frequency in the Irish population.

Authors:  L A Mynett-Johnson; C Keenan; I L Black; W J Livingstone; M Lawler; H M Roche; B White; M J Gibney; P McKeon; O P Smith
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

4.  Simultaneous allele-specific amplification: a strategy using modified primer-template mismatches for SNP detection--application to prothrombin 20210A (factor II) and factor V Leiden (1691A) gene mutations.

Authors:  S A DelRio-LaFreniere; R C McGlennen
Journal:  Mol Diagn       Date:  2001-09

Review 5.  Humans, mice, and mechanisms of intestinal atresias: a window into understanding early intestinal development.

Authors:  Peter F Nichol; Amy Reeder; Robert Botham
Journal:  J Gastrointest Surg       Date:  2010-11-30       Impact factor: 3.452

6.  Thrombus obstructing the right ventricle outflow tract in a neonate with methylenetetrahydrofolate reductase 677TT genotype.

Authors:  Lubica Kovacikova; Peter Skrak; Martin Zahorec
Journal:  Eur J Pediatr       Date:  2011-03-08       Impact factor: 3.183

7.  Distribution of MTHFR C677T Gene Polymorphism in Healthy North Indian Population and an Updated Meta-analysis.

Authors:  Upendra Yadav; Pradeep Kumar; Sanjay Gupta; Vandana Rai
Journal:  Indian J Clin Biochem       Date:  2016-10-11

8.  COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence.

Authors:  Giovanni Ponti; Lorenza Pastorino; Marco Manfredini; Tomris Ozben; Gabriella Oliva; Shaniko Kaleci; Raffaele Iannella; Aldo Tomasi
Journal:  J Clin Lab Anal       Date:  2021-06-01       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.